PURPOSE: To provide early-stage investigators with support and protected time (up to five years) for intensive, research-focused career development program activities under the guidance of an experienced mentorship team with expertise in both the preclinical application of nonhuman primate (NHP) models and in translation of the results from such studies to clinical application. The focus…Continue Reading Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01)
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01)
Purpose: To provide salary and research support to investigators who are within ten years of completing their terminal professional degree or residency training. Research and mentorship must be in the field of HIV/AIDS translational studies, using nonhuman primates (NHPs) as preclinical models. These awards will provide 3 years of support for intensive research career development under…Continue Reading HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01)
Notice of Special Interest (NOSI): HIV Cure-Related Research in Diverse Populations
PURPOSE: To highlight NIAID’s interest in HIV cure-related research in diverse cohorts of people living with HIV to determine similarities and differences in the establishment and dynamics of persistent non-subtype B HIV reservoirs, as well as in post-treatment control of viremia. Standard AIDS due dates:…Continue Reading Notice of Special Interest (NOSI): HIV Cure-Related Research in Diverse Populations
Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation (R21, R01)
PURPOSE: To identify new opportunities for cure interventions administered during active HIV infection at or near the start of antiretroviral therapy (ART) or as a potential replacement for conventional ART with the ultimate goal of achieving a sustained ART-free HIV remission. STANDARD AIDS DUE DATES:…Continue Reading Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation (R21, R01)